We and others have shown that genomic disruption of the MIG6 gene orchestrates constitutive EGFR signaling resulting in degenerative joint diseases, skin hyperplasia, melanomas, and lung cancer in mice [16, 17]. This evidence concerns the gene EGFR and lung carcinoma.